[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fFXp3gQBFttp0yhleroifhKaJiEN3x589lL4GV_mhBP0":8,"$fuGCRPG7cnwZhKAgaedukLBN8XZHkjqcON978N5nbLn8":55,"$fJtRpDUwUZvgPxd1sjw30IrNpBJHWtZ9stLf8u_BX6Os":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},55670,867283,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//o1oe1SwU3vlGsqy95secRlqRH2wkEV8k.png","王俊","烟台高新技术产业开发区医院","普通内科","主治医师",416,0,"仑伐替尼（Lenvatinib）用药全指南：安全高效使用的7个关键细节","","https://ystcdn.venuertc.com/venue/AI/21804f33-ef3a-460b-9f27-eb691dfaf085.jpg","\u003Cdiv class=\"lenvatinib-article-container\" style=\"background:#f8fbfc;padding:36px 28px 28px 28px;max-width:920px;margin:36px auto 30px auto;border-radius:14px;box-shadow:0 4px 24px rgba(71,122,155,0.07);font-family:'Segoe UI',Arial,sans-serif;font-size:18px;line-height:1.85;color:#263643;\">\n\n  \u003Ch1 id=\"material_title\" class=\"lenvatinib-main-title\" style=\"font-size: 2.3rem; line-height: 1.25; margin: 1.2em 0px 0.6em; letter-spacing: 0.6px; font-weight: 700; text-align: center; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">\n    仑伐替尼（Lenvatinib）用药全指南：安全高效使用的7个关键细节\n  \u003C/h1>\n\n  \u003Cdiv class=\"lenvatinib-intro\" style=\"background:linear-gradient(90deg,#f4f7fa 60%,#eaf0f8 100%);border-radius:12px;padding:22px 28px;margin-bottom:30px;\">\n    \u003Cspan style=\"font-size:1.28em;\">👋\u003C/span>\n    \u003Cspan style=\"margin-left:8px;\">说起仑伐替尼，这是一种常用于肿瘤治疗的靶向口服药物。越来越多的患者在治疗中接触到它，但真正了解怎么用、有哪些注意事项的人其实不多。本文将带你全面梳理仑伐替尼的7个用药关键点，包括服用方法、剂量、相互作用、常见副作用等实用细节，让你和家人用药更安心。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 01剂型成分与作用机制 -->\n  \u003Cdiv class=\"lenvatinib-section\" style=\"margin-bottom:38px;\">\n    \u003Ch2 class=\"lenvatinib-section-title\" style=\"font-size: 1.35em; font-weight: 700; background: linear-gradient(100deg, rgb(222, 221, 251) 75%, rgb(237, 239, 237) 100%); padding: 16px 20px; border-radius: 9px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      01 仑伐替尼的成分、剂型及作用机制\n    \u003C/h2>\n    \u003Cul class=\"lenvatinib-content-list\" style=\"margin:19px 0 0 22px;\">\n      \u003Cli>\u003Cstrong>主要成分：\u003C/strong>\n        仑伐替尼（Lenvatinib）为化学合成的小分子靶向药品。\u003C/li>\n      \u003Cli>\u003Cstrong>剂型和规格：\u003C/strong>\n        目前临床常见为口服胶囊、片剂。常用规格为4mg、10mg两种胶囊。\u003C/li>\n      \u003Cli>\u003Cstrong>工作机制：\u003C/strong>\n        它通过抑制VEGFR、FGFR等多种酪氨酸激酶，切断肿瘤细胞的“养分供给线”，阻断肿瘤微血管生成、延缓肿瘤进展。\u003Cspan style=\"color:#789ee7\">(Matsuki et al., 2018)\u003C/span>\u003C/li>\n      \u003Cli>\n        \u003Cspan style=\"color:#19647e;\">正确做法：\u003C/span>\n        理解药品机制有助于理解它为何能作为多种肿瘤的一线选择之一。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003C!-- 02最佳服用时间与方法 -->\n  \u003Cdiv class=\"lenvatinib-section\" style=\"margin-bottom:38px;\">\n    \u003Ch2 class=\"lenvatinib-section-title\" style=\"font-size: 1.35em; font-weight: 700; background: linear-gradient(100deg, rgb(232, 246, 234) 60%, rgb(231, 242, 250) 100%); padding: 16px 20px; border-radius: 9px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      02 正确的服用时间和方法\n    \u003C/h2>\n    \u003Cul class=\"lenvatinib-content-list\" style=\"margin:18px 0 0 22px;\">\n      \u003Cli>\n        \u003Cstrong>每次服用时间：\u003C/strong>\n        仑伐替尼\u003Cem>建议每日一次，在大致相同时间服用\u003C/em>，可随餐或空腹服用（说明书未强制要求与餐饮同步）。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>服药方式：\u003C/strong>\n        胶囊/片剂需要整粒吞咽，\u003Cem>不可咀嚼、压碎或溶解\u003C/em>。建议用一大杯温水送服，不要用果汁、茶等替代。\u003C/li>\n      \u003Cli>\n        \u003Cspan style=\"color:#577990;\">正确做法：\u003C/span>\n        每日定点服药，养成习惯，避免漏服。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv style=\"margin:8px 0 0 22px;color:#39936e;font-size:1em;\">\n      💡\n      例：有位患者采用4mg每日一次的方案，坚持每晚七点饭后吞服，坚持了次月复查时发现未见明显不良反应。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 03 剂量调整与漏服处理 -->\n  \u003Cdiv class=\"lenvatinib-section\" style=\"margin-bottom:38px;\">\n    \u003Ch2 class=\"lenvatinib-section-title\" style=\"font-size: 1.35em; font-weight: 700; background: linear-gradient(100deg, rgb(246, 236, 216) 70%, rgb(238, 247, 244) 100%); padding: 16px 20px; border-radius: 9px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      03 剂量选择、调整及漏服/过量处理\n    \u003C/h2>\n    \u003Cul class=\"lenvatinib-content-list\" style=\"margin:18px 0 0 22px;\">\n      \u003Cli>\u003Cstrong>初始用量：\u003C/strong>\n        成人常用起始剂量为8mg/d（体重＜60kg者）或12mg/d（体重≥60kg者）。部分特殊患者（如肝功能障碍等）可能给予更低起始剂量。\u003C/li>\n      \u003Cli>\u003Cstrong>剂量调整：\u003C/strong>\n        出现不良反应时，可在医生指导下分级减量，常见调整幅度为8mg、4mg、甚至最低至4mg/d。\u003C/li>\n      \u003Cli>\u003Cstrong>漏服处理：\u003C/strong>\n        若当日想起漏服，补服；若临近下次服药时间，直接跳过漏服，不要追加剂量。\u003C/li>\n      \u003Cli>\u003Cstrong>过量风险：\u003C/strong>\n        超量服用可加重副作用（如高血压、肝肾损害）。出现异常不适需立即停药，尽快就医。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv style=\"margin:8px 0 0 22px;color:#d29132;font-size:1em;\">\n      🗒️\n      相关数据：公开研究显示，仑伐替尼相关不良反应的发生与剂量相关（Kudo et al., 2018）。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 04 不良反应与处理建议 -->\n  \u003Cdiv class=\"lenvatinib-section\" style=\"margin-bottom:40px;\">\n    \u003Ch2 class=\"lenvatinib-section-title\" style=\"font-size: 1.35em; font-weight: 700; background: linear-gradient(100deg, rgb(233, 229, 250) 62%, rgb(236, 237, 234) 100%); padding: 16px 20px; border-radius: 9px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      04 常见不良反应及处理办法\n    \u003C/h2>\n    \u003Cul class=\"lenvatinib-content-list\" style=\"margin:18px 0 0 22px;\">\n      \u003Cli>\u003Cstrong>常见不良反应：\u003C/strong> 包括高血压、食欲下降、疲劳、腹泻、蛋白尿、手足综合征等。大多数为轻中度，部分患者需调整剂量。\u003C/li>\n      \u003Cli>\u003Cstrong>严重不良反应：\u003C/strong> 极少数患者可出现肝肾损伤、严重出血。\u003Cspan style=\"color:#ce0f2f;font-weight:600;\">如有明显异常症状，应立即停药并及时就医。\u003C/span>\u003C/li>\n      \u003Cli>\u003Cstrong>处理对策：\u003C/strong> 轻度症状时多补水、注意休息，若不适加重及时寻求医生帮助。\u003C/li>\n      \u003Cli>数据显示，临床中不良反应总体可控，多数患者能耐受 (Kudo, 2018)。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lenvatinib-case\" style=\"margin:10px 0 0 22px;color:#8b71aa;font-size:1em;\">🌱\n      临床案例：一位老年患者在服用10mg时出现轻度高血压，经医生减量至4mg后血压恢复平稳，后续未再出现明显不适。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 05 药物相互作用细节 -->\n  \u003Cdiv class=\"lenvatinib-section\" style=\"margin-bottom:38px;\">\n    \u003Ch2 class=\"lenvatinib-section-title\" style=\"font-size: 1.35em; font-weight: 700; background: linear-gradient(100deg, rgb(247, 231, 231) 65%, rgb(233, 246, 250) 100%); padding: 16px 20px; border-radius: 9px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      05 药物相互作用需要知道什么？\n    \u003C/h2>\n    \u003Cul class=\"lenvatinib-content-list\" style=\"margin:18px 0 0 22px;\">\n      \u003Cli>\u003Cstrong>常见影响药物：\u003C/strong>\n        仑伐替尼主要通过肝脏代谢，和强效CYP3A4抑制剂或诱导剂（如某些抗生素、癫痫药、圣约翰草等）合用时可影响血药浓度。\u003C/li>\n      \u003Cli>\u003Cstrong>与抗凝药、抗高血压药：\u003C/strong>\n        与华法林、阿司匹林等抗凝药合用可增加出血风险，与部分降压药合用建议加强血压监测。\u003C/li>\n      \u003Cli>\u003Cstrong>与食物关系：\u003C/strong>\n        食物对药物吸收影响较小，但应避免与高脂食物同时大量进食。\u003C/li>\n      \u003Cli>\u003Cspan style=\"color:#e2b226;\">特别提醒：\u003C/span> 服药期间如需加用其他药物，应主动咨询医生或药师，避免不必要的风险。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003C!-- 06 适应症与禁忌症分明 -->\n  \u003Cdiv class=\"lenvatinib-section\" style=\"margin-bottom:38px;\">\n    \u003Ch2 class=\"lenvatinib-section-title\" style=\"font-size: 1.35em; font-weight: 700; background: linear-gradient(100deg, rgb(235, 238, 219) 60%, rgb(215, 236, 231) 100%); padding: 16px 20px; border-radius: 9px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      06 仑伐替尼适应症与禁忌症简明\n    \u003C/h2>\n    \u003Cul class=\"lenvatinib-content-list\" style=\"margin:19px 0 0 22px;\">\n      \u003Cli>\u003Cstrong>适应症：\u003C/strong> 用于多种晚期实体肿瘤的治疗，包括肝癌、甲状腺癌、肾癌等。用药前请勿自我判断，一切以医生处方为准。\u003C/li>\n      \u003Cli>\u003Cstrong>禁忌症：\u003C/strong>\n        对仑伐替尼或成分过敏者严禁使用；严重肝、肾功能损害患者慎用；孕妇、哺乳期女性禁用。\u003C/li>\n      \u003Cli>\u003Cspan style=\"color:#b67b15;\">需要注意：\u003C/span>\n        患有心血管病、消化道出血史、蛋白尿等病史的患者用药前务必提前说明。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003C!-- 07 特殊人群用药调整 -->\n  \u003Cdiv class=\"lenvatinib-section\" style=\"margin-bottom:38px;\">\n    \u003Ch2 class=\"lenvatinib-section-title\" style=\"font-size: 1.35em; font-weight: 700; background: linear-gradient(100deg, rgb(227, 246, 239) 80%, rgb(243, 250, 255) 100%); padding: 16px 20px; border-radius: 9px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      07 特殊人群用药调整要诀\n    \u003C/h2>\n    \u003Cul class=\"lenvatinib-content-list\" style=\"margin:19px 0 0 22px;\">\n      \u003Cli>\u003Cstrong>肝肾功能不全患者：\u003C/strong> \n        轻度肝肾功能受损者一般无需调整剂量，中重度需酌情减少，需遵医嘱。\u003C/li>\n      \u003Cli>\u003Cstrong>老年患者：\u003C/strong>\n        老年人药物代谢变慢，更易出现副作用；建议严密监测，剂量个性化调整。\u003C/li>\n      \u003Cli>\u003Cstrong>儿童、孕妇及哺乳期妇女：\u003C/strong>\n        未成年人慎用，孕妇与哺乳期女性禁用。\u003C/li>\n      \u003Cli>\u003Cstrong>糖尿病或高血压患者：\u003C/strong>\n        服药期间需密切监测血糖、血压变化。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lenvatinib-case\" style=\"margin:10px 0 0 22px;color:#36a689;font-size:1em;\">🧩\n      服药案例：一位同时使用降压药和胰岛素的中老年女性，按4mg/日方案规律服用仑伐替尼，期间定期监测血压和血糖，配合饮食控制，全程未出现严重药物相互作用。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 08 储存与药品管理 -->\n  \u003Cdiv class=\"lenvatinib-section\" style=\"margin-bottom:38px;\">\n    \u003Ch2 class=\"lenvatinib-section-title\" style=\"font-size: 1.35em; font-weight: 700; background: linear-gradient(100deg, rgb(232, 235, 250) 70%, rgb(246, 248, 230) 100%); padding: 16px 20px; border-radius: 9px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      08 正确的储存与用药管理\n    \u003C/h2>\n    \u003Cul class=\"lenvatinib-content-list\" style=\"margin:18px 0 0 22px;\">\n      \u003Cli>\u003Cstrong>储存温度：\u003C/strong>\n        建议常温保存于25℃以下，避免湿气和高温，不要放浴室、厨房等潮湿处。\u003C/li>\n      \u003Cli>\u003Cstrong>保存期限：\u003C/strong>\n        未开封视有效期为准，开封后务必于说明书建议期限内服用完毕。\u003C/li>\n      \u003Cli>\u003Cstrong>药品管理：\u003C/strong>\n        远离儿童及宠物，勿将剩余药品随意丢弃或与其他药品混合存放。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv style=\"margin:10px 0 0 22px;color:#b0c1e6;font-size:1em;\">🗃️\n      小贴士：如需医保报销或外出携带，务必带好包装盒及说明书以备查验。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 小结 -->\n  \u003Cdiv class=\"lenvatinib-summary\" style=\"background:linear-gradient(90deg,#f0f4e7 80%,#f8f3f7 100%);border-radius:12px;padding:20px 25px;margin-top:22px;\">\n    \u003Cstrong style=\"color:#237951;font-size:1.18em;\">总结：\u003C/strong>\n    \u003Cspan style=\"color:#445767;\">仑伐替尼作为靶向抗肿瘤药物，效果肯定，但安全用药的前提是“懂细节”。记住：用量合适、用法正确、慎防相互作用，出现异常及时就医，是保证疗效、降低风险的关键。理解这些要点，会让你的治疗更有信心。\u003C/span>\n    \u003Cbr>\n    \u003Cspan style=\"color:#547abd;font-size:1.08em;\">\u003Cstrong>📮 如有疑问，随时咨询专业医生或药师。\u003C/strong>\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 参考文献 -->\n  \u003Cdiv class=\"lenvatinib-refs\" style=\"margin:37px 0 0 0;padding:0 0 0 8px;\">\n    \u003Ch3 style=\"font-size: 1.07em; color: rgb(44, 62, 80); background: rgb(248, 248, 241); border-radius: 7px; padding: 10px 15px 7px; margin: 1.2em 0px 0.6em; display: inline-block; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">References\u003C/h3>\n    \u003Col style=\"margin-left:25px;font-size:0.97em;color:#6c6a67;\">\n      \u003Cli>Matsuki, M., Hoshi, T., Yamamoto, Y., Kimura, T., Matsui, J. (2018). Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human cancer models. \u003Ci>European Journal of Cancer Supplements, 16(2), 7–12.\u003C/i>\u003C/li>\n      \u003Cli>Kudo, M. (2018). Lenvatinib as an Initial Treatment in Unresectable Hepatocellular Carcinoma: A Review of Results from the Phase 3 REFLECT Study and Real‐World Evidence. \u003Ci>Liver Cancer, 7(2), 111–122.\u003C/i> https://doi.org/10.1159/000488114\u003C/li>\n      \u003Cli>Lenvatinib [package insert]. (2023). Tokyo, Japan: Eisai Co., Ltd.\u003C/li>\n      \u003Cli>Ikeda, K., et al. (2021). Safety and effectiveness of lenvatinib in Japanese patients with unresectable hepatocellular carcinoma: Real-world experience. \u003Ci>Cancer Science, 112(2), 838-846.\u003C/i> https://doi.org/10.1111/cas.14759\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.lenvatinib-article-container { box-sizing:border-box; }\n.lenvatinib-main-title { letter-spacing:1px; }\n.lenvatinib-content-list li { margin-bottom:10px;padding-left:4px;}\n.lenvatinib-section-title { margin-top:0;margin-bottom:10px; }\n.lenvatinib-case { font-style:italic; }\n@media (max-width: 600px) {\n  .lenvatinib-article-container { padding:11px 2.2vw 12px 2.2vw; }\n  .lenvatinib-section-title { font-size:1.09em;padding:10px 10px; }\n  .lenvatinib-intro { padding:12px 7px 10px 7px;}\n  .lenvatinib-summary { padding:10px 7px; }\n}\n\u003C/style>\n","\u003Cdiv class=\"lenvatinib-article-container\" style=\"background:#f8fbfc;padding:36px 28px 28px 28px;max-",414,"2025-08-05 11:19:26","仑伐替尼, 癌症治疗, 不良反应, 服用方法, 剂量调整, 药物相互作用, 安全用药, 靶向药物","了解仑伐替尼的7个关键用药要点，助力患者安全高效治疗癌症。掌握服用方法、副作用管理及注意事项，让健康更有保障。","2025-08-10 09:50:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]